Dallah Healthcare Company Statistics

Total Valuation

Dallah Healthcare Company has a market cap or net worth of SAR 14.90 billion. The enterprise value is 17.02 billion.

Market Cap	14.90B
Enterprise Value	17.02B

Important Dates

The last earnings date was Thursday, November 7, 2024.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	Nov 18, 2024

Share Statistics

Dallah Healthcare Company has 97.38 million shares outstanding. The number of shares has increased by 2.30% in one year.

Current Share Class	n/a
Shares Outstanding	97.38M
Shares Change (YoY)	+2.30%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	9.69%
Owned by Institutions (%)	3.90%
Float	40.36M

Valuation Ratios

The trailing PE ratio is 31.72 and the forward PE ratio is 29.41. Dallah Healthcare Company's PEG ratio is 1.49.

PE Ratio	31.72
Forward PE	29.41
PS Ratio	4.66
PB Ratio	4.36
P/TBV Ratio	n/a
P/FCF Ratio	41.47
P/OCF Ratio	n/a
PEG Ratio	1.49

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.58, with an EV/FCF ratio of 47.37.

EV / Earnings	36.13
EV / Sales	5.31
EV / EBITDA	22.58
EV / EBIT	27.55
EV / FCF	47.37

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.55.

Current Ratio	1.11
Quick Ratio	0.79
Debt / Equity	0.55
Debt / EBITDA	2.82
Debt / FCF	5.67
Interest Coverage	5.57

Financial Efficiency

Return on equity (ROE) is 13.95% and return on invested capital (ROIC) is 6.61%.

Return on Equity (ROE)	13.95%
Return on Assets (ROA)	5.77%
Return on Capital (ROIC)	6.61%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.50
Inventory Turnover	8.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.13% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.13%
50-Day Moving Average	157.89
200-Day Moving Average	165.32
Relative Strength Index (RSI)	43.23
Average Volume (20 Days)	44,684

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dallah Healthcare Company had revenue of SAR 3.20 billion and earned 470.95 million in profits. Earnings per share was 4.82.

Revenue	3.20B
Gross Profit	1.15B
Operating Income	586.15M
Pretax Income	512.33M
Net Income	470.95M
EBITDA	697.92M
EBIT	586.15M
Earnings Per Share (EPS)	4.82

Full Income Statement

Balance Sheet

The company has 208.22 million in cash and 2.04 billion in debt, giving a net cash position of -1.83 billion or -18.78 per share.

Cash & Cash Equivalents	208.22M
Total Debt	2.04B
Net Cash	-1.83B
Net Cash Per Share	-18.78
Equity (Book Value)	3.70B
Book Value Per Share	35.07
Working Capital	138.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 779.46 million and capital expenditures -420.21 million, giving a free cash flow of 359.25 million.

Operating Cash Flow	779.46M
Capital Expenditures	-420.21M
Free Cash Flow	359.25M
FCF Per Share	3.69

Full Cash Flow Statement

Margins

Gross margin is 35.99%, with operating and profit margins of 18.30% and 14.70%.

Gross Margin	35.99%
Operating Margin	18.30%
Pretax Margin	16.00%
Profit Margin	14.70%
EBITDA Margin	21.79%
EBIT Margin	18.30%
FCF Margin	11.22%

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 0.98%.

Dividend Per Share	1.50
Dividend Yield	0.98%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	n/a
Payout Ratio	41.44%
Buyback Yield	-2.30%
Shareholder Yield	-1.32%
Earnings Yield	3.15%
FCF Yield	2.41%

Dividend Details

Stock Splits

The last stock split was on September 14, 2020. It was a forward split with a ratio of 1.2.

Last Split Date	Sep 14, 2020
Split Type	Forward
Split Ratio	1.2

Scores

Dallah Healthcare Company has an Altman Z-Score of 4.46.

Altman Z-Score	4.46
Piotroski F-Score	n/a